Plasminogen activator inhibitor-1 (PAI-1), the primary inhibitor of fibrinolysis, is upregulated in IPF patients’ lungs, correlating with disease severity [21]. The gene discussed is SERPINE1; the disease is idiopathic pulmonary fibrosis.